Trials / Available
AvailableNCT07119775
Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- AMO Pharma Limited · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tideglusib |
Timeline
- First posted
- 2025-08-13
- Last updated
- 2025-08-13
Source: ClinicalTrials.gov record NCT07119775. Inclusion in this directory is not an endorsement.